Home Healthcare Market

Abbott (US), F. hoffmann-la roche ltd (Switzerland) and GE Healthcare (US) are Leading Players in the Home Healthcare Market

The global home healthcare market size is projected to reach USD 298.2 billion by 2026 from USD 198.9 billion in 2021, at a CAGR of 8.4% during the forecast period. Market growth is driven mainly by factors such as rapid growth in the elderly population, the rising incidence of chronic diseases, the growing need for cost-effective healthcare delivery due to the increasing healthcare costs, and technological advancements in home care devices. The emerging Asian countries are also expected to offer substantial growth opportunities for players in the market.

The global home healthcare market is highly fragmented. The prominent players in the global home healthcare industry include Fresenius SE & Co. KGaA (Germany), GE Healthcare (US), Linde plc (Ireland), F. Hoffmann-La Roche Ltd (Switzerland), A&D Company (Japan), BAYADA Home Health Care (US), Invacare Corporation (US), Abbott (US), Amedisys (US), ResMed (US), LHC Group, Inc. (US), OMRON Corporation (Japan), Koninklijke Philips N.V. (Netherlands), Drive DeVilbiss Healthcare (US), Hamilton Medical (Switzerland), Sunrise Medical (Germany), Roma Medical (UK), Caremax Rehabilitation Equipment Co., Ltd(China), Vitalograph (UK), Advita Pflegedienst GmbH (Germany), RENAFAN GmbH (Germany), ADMR (France), Apex Medical Corporation (Taiwan), CONTEC MEDICAL SYSTEMS CO., LTD (China), and Löwenstein Medical Technology GmbH + Co. KG. (Germany).

To know about the assumptions considered for the study download the pdf brochure

Abbott (US) is one of the major players of blood glucose monitor in the home healthcare market with a share of 8.4% in 2020. The company has a strong product portfolio in the home healthcare market, especially blood glucose meters. It has a strong geographic presence across the globe and invests a significant amount of its revenue in R&D. In FY 2020, Abbott invested 6.9% of its total revenue in R&D.

F. hoffmann-la roche ltd (Switzerland) is one of the prominent players of blood glucose monitor in the home healthcare market with a share of 3.6% in 2020. Roche is known for its strong portfolio in diagnostics and is the frontrunner in diabetes management. The diabetes care product portfolio offers an integrated, collaborative, and personalized approach that aims to determine the optimal therapy for each person with diabetes. The company invests a significant part of its revenue in R&D. It has constantly increased its R&D investments to accelerate innovative product development. In FY 2020, the company invested about USD 13.8 billion in R&D, which witnessed an increase of 7.9% as compared to FY 2019. These investments were aimed at discovering, testing, and developing new products and improving existing products

GE Healthcare (US) is one of the prominent players of blood glucose monitor in the home healthcare market with a share of 3.0% in 2020. its expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, drug discovery, biopharmaceutical manufacturing technologies, and life care solutions.

Related Reports:

Home Healthcare Market by Product (Dialysis Equipment, IV Equipment, Ventilators, Coagulation Monitors, Peak Flow Meters), Service (Infusion Therapy, Skilled Nursing, Hospice), Indication (Cancer, Wound Care, Diabetes), & Region - Global Forecast to 2026

Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]

Report Code
MD 1160
RI Published ON
11/30/2021
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the Home Healthcare Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
©2022 MarketsandMarkets Research Private Ltd. All rights reserved